Live Breaking News & Updates on Hormone Receptor Positivity

Stay updated with breaking news from Hormone receptor positivity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Neoadjuvant KN026 Plus Docetaxel Demonstrate Early Activity in HER2+ Breast Cancer

A combination of KN026, a novel bispecific antibody, and docetaxel elicited responses with an acceptable toxicity profile when administered as neoadjuvant treatment in patients with HER2-positive (HER2+) early or locally advanced breast cancer. ....

Lin Xiaoxi Ma , European Society For Medical Oncology Congress , Eastern Cooperative Oncology Group , Crystal Light , Medical Oncology , Bispecific Antibody , Neoadjuvant Treatment , Breast Cancer , Her2 Positive , Hormone Receptor Positivity ,